Healthcare >> CEO Interviews >> May 13, 2003

Andrew Meadow – Healthcon Corporation

ANDREW MEADOW is a General Partner of Healthcon Corp. Mr. Meadow concentrated the last 14 years in a variety of senior management roles, the focus of which was to craft opportunities, define appropriate strategies, valuing the financial implications underpinning what products can and should be launched, and creating decisive analytical and quantitative approaches that help monetize business plans and launch cutting edge technologies and therapies. In conjunction with his financial due diligence and corporate valuation efforts, Mr. Meadow has been an advocate of using innovative quantitative methods to ascertain the risk profile of a transaction, including how real option and probability analysis can assist management in mitigating the risk associated with some transactions. Prior to HealthCon, Mr. Meadow worked for Essex Woodlands Health Care Ventures in evaluating private equity/venture technology opportunities within the healthcare services, diagnostics and device arenas. Prior to this experience, Mr. Meadow served as the Manager for Baxter International's Corporate Business Development Team. At Baxter, he evaluated multiple biotechnology ventures as well as emerging treatments and products for joint venture, acquisition, technology transfer, new product development and licensing opportunities within the oncology, tissue engineering, cell and gene therapy, and bioscience arenas. Before Baxter, Mr. Meadow served on UBS Warburg's Global Healthcare Investment Banking Team where he worked on a significant number of M&A, high-yield debt, private placement, follow-on, and IPO transactions within the healthcare industry. Mr. Meadow completed his MBA in Health Care Finance and Strategy at Case Western Reserve University's Weatherhead School of Management where he was a recipient of the Weatherhead Merit Scholarship. In addition, Mr. Meadow has completed Advanced Master's degree studies in Health Care and International Economics at the Rotterdam School of Management's Erasmus University. Before embarking upon his career, Mr. Meadow graduated with honors and academic distinction from Franklin and Marshall College, where he was a four year varsity letterman in three different sports. Prior to completing his MBA, Mr. Meadow worked for nine years in Central and Eastern Europe in a variety of executive level positions in the areas of product development, corporate restructuring, treasury and financial control. During his tenure in Europe, Mr. Meadow gained extensive operational experience in managing early stage health and consumer goods concerns throughout Central and Eastern Europe. Mr. Meadow is fluent in Polish and Russian. Profile
TWST: What do you see as HealthCon Corp.'s business and mission

today?

Mr. Meadow: HealthCon's business model brings a unique

combination of industry expertise, scientific acumen and

extensive